← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 11, 2017Last known activity
Dec 18, 2025
Timeline
2010s
- Jun 1, 2012
Shanghai JMT-Bio Inc.— Founded
Drugs by trial phase (36 distinct, 34 trials)
Phase 3 (18 own, 0 via acquisition)
Phase 2 (16 own, 0 via acquisition)
Indications
Recent trials (34)
- NCT07280832Lead sponsorPhase 1/Phase 2Dec 18, 2025
- NCT07134205Lead sponsorPhase 3Oct 1, 2025
- NCT07275073Lead sponsorPhase 1Sep 25, 2025
- NCT07140809Lead sponsorPhase 1/Phase 2Sep 9, 2025
- NCT07029139Lead sponsorPhase 2Jun 30, 2025
- NCT06998771Lead sponsorPhase 2Jun 15, 2025
- NCT06846437Lead sponsorPhase 3Apr 30, 2025
- NCT06877650Lead sponsorPhase 1/Phase 2Apr 11, 2025
- NCT06892431Lead sponsorPhase 2Apr 1, 2025
- NCT06908772Lead sponsorPhase 2/Phase 3Apr 1, 2025
- NCT06829459Lead sponsorPhase 3Feb 15, 2025
- NCT06747338Lead sponsorPhase 3Dec 16, 2024
- NCT06735391Lead sponsorPhase 3Oct 23, 2024
- NCT06564467Lead sponsorPhase 1Jul 23, 2024
- NCT06868849Lead sponsorPhase 1May 15, 2024
Details
- Founded
- Shanghai, CN Jun 1, 2012
- Last known activity
- Dec 18, 2025